BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35073431)

  • 1. Incident bullous pemphigoid in a psoriatic patient following mRNA-1273 SARS-CoV-2 vaccination.
    Hung WK; Chi CC
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e407-e409. PubMed ID: 35073431
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of acquired hemophilia A and bullous pemphigoid following SARS-CoV-2 mRNA vaccination.
    Fu PA; Chen CW; Hsu YT; Wei KC; Lin PC; Chen TY
    J Formos Med Assoc; 2022 Sep; 121(9):1872-1876. PubMed ID: 35321820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bullous pemphigoid after SARS-CoV-2 vaccination: spike-protein-directed immunofluorescence confocal microscopy and T-cell-receptor studies.
    Gambichler T; Hamdani N; Budde H; Sieme M; Skrygan M; Scholl L; Dickel H; Behle B; Ganjuur N; Scheel C; Abu Rached N; Ocker L; Stranzenbach R; Doerler M; Pfeiffer L; Becker JC
    Br J Dermatol; 2022 Apr; 186(4):728-731. PubMed ID: 34773638
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid.
    Solimani F; Mesas-Fernández A; Bodner E; Carevic-Neri M; Hasheminasab M; Jakovljevicova T; Philipp A; Nast A; Worm M; Hilke FJ; Meier K; Ghoreschi K
    J Eur Acad Dermatol Venereol; 2023 Jun; 37(6):e695-e697. PubMed ID: 36786360
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.
    Larson V; Seidenberg R; Caplan A; Brinster NK; Meehan SA; Kim RH
    J Cutan Pathol; 2022 Jan; 49(1):34-41. PubMed ID: 34292611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.
    Maeda M; Isawa T; Tada N
    Circ J; 2022 Mar; 86(4):724. PubMed ID: 34866122
    [No Abstract]   [Full Text] [Related]  

  • 7. Bullous pemphigoid and COVID-19 vaccination: Management and treatment reply to 'Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: A report and brief literature review' by Pauluzzi et al.
    Martora F; Ruggiero A; Battista T; Fabbrocini G; Megna M
    J Eur Acad Dermatol Venereol; 2023 Jan; 37(1):e35-e36. PubMed ID: 35974447
    [No Abstract]   [Full Text] [Related]  

  • 8. Myocarditis after vaccination against covid-19.
    Gellad WF
    BMJ; 2021 Dec; 375():n3090. PubMed ID: 34916217
    [No Abstract]   [Full Text] [Related]  

  • 9. Bullous pemphigoid induced by the AstraZeneca COVID-19 vaccine.
    Agharbi FZ; Eljazouly M; Basri G; Faik M; Benkirane A; Albouzidi A; Chiheb S
    Ann Dermatol Venereol; 2022 Mar; 149(1):56-57. PubMed ID: 34686374
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of bullous pemphigoid after the SARS-CoV-2 mRNA vaccine.
    Young J; Mercieca L; Ceci M; Pisani D; Betts A; Boffa MJ
    J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):e13-e16. PubMed ID: 34547137
    [No Abstract]   [Full Text] [Related]  

  • 11. Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report.
    Masuccio FG; Comi C; Solaro C
    Acta Neurol Belg; 2022 Oct; 122(5):1369-1371. PubMed ID: 34767184
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoimmune skin disorders and SARS-CoV-2 vaccination - a meta-analysis.
    Hinterseher J; Hertl M; Didona D
    J Dtsch Dermatol Ges; 2023 Aug; 21(8):853-861. PubMed ID: 37218538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral mucous membrane pemphigoid after SARS-CoV-2 vaccination.
    Calabria E; Antonelli A; Lavecchia A; Giudice A
    Oral Dis; 2024 Mar; 30(2):782-783. PubMed ID: 36516333
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.
    Steensels D; Pierlet N; Penders J; Mesotten D; Heylen L
    JAMA; 2021 Oct; 326(15):1533-1535. PubMed ID: 34459863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.
    Wang M; Wen W; Zhou M; Wang C; Feng ZH
    Am J Cardiol; 2022 Mar; 167():155-157. PubMed ID: 35063268
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 vaccines surveillance in France: a global response to a major national challenge.
    Benkebil M; Gautier S; Gras-Champel V; Massy N; Micallef J; Valnet Rabier MB
    Anaesth Crit Care Pain Med; 2021 Jun; 40(3):100866. PubMed ID: 33895471
    [No Abstract]   [Full Text] [Related]  

  • 17. Aortic Mural Thrombosis Diagnosed After a Second Dose of mRNA-1273 SARS-CoV-2 Vaccine.
    Punjwani S; Khanna P; Jani C; Waston J; Behlau I
    Am J Ther; 2022 May-Jun 01; 29(3):e358-e361. PubMed ID: 35533327
    [No Abstract]   [Full Text] [Related]  

  • 18. Sensitization to trometamol in patients with delayed local reactions after administration of the Moderna mRNA-1273 vaccine against SARS-CoV-2.
    Davila-Fernandez G; Sanchez-Moreno GV; Madrigal-Burgaleta R
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2166-2168.e1. PubMed ID: 35513307
    [No Abstract]   [Full Text] [Related]  

  • 19. A new eruption of bullous pemphigoid following mRNA COVID-19 vaccination.
    Daines B; Madigan LM; Vitale PA; Khalighi M; Innes M
    Dermatol Online J; 2022 Aug; 28(4):. PubMed ID: 36259862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-limited Polymyalgia Rheumatica-like Syndrome Following mRNA-1273 SARS-CoV-2 Vaccination.
    Izuka S; Komai T; Natsumoto B; Shoda H; Fujio K
    Intern Med; 2022 Mar; 61(6):903-906. PubMed ID: 34980802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.